NHS England are introducing a new way of analysing cervical screening results.
This should help identify more at risk women and subsequently reduce the number of cervical cancer cases.
The new analysis will see Human Papillomavirus testing replace the current cytology testing.
The transition should be completed by 2019 but there are concerns that the transition is causing delays and backlogs.
Changes to cervical smear test explained Cytology is currently the first test performed on all screening samples but will be replaced by Human Papillomavirus testing This new test brings added benefits for women and will prevent more cases of cervical cancer. Once implemented, the requirement for cytology will be considerably reduced.